Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-15), Inspire Medical Systems's 3-1 Month Momentum % is 18.64%.
The industry rank for Inspire Medical Systems's 3-1 Month Momentum % or its related term are showing as below:
FRA:2DR's 3-1 Month Momentum % is ranked better than 90.82% of 850
companies
in the Medical Devices & Instruments industry
Industry Median: -7.445
vs FRA:2DR: 18.64
Inspire Medical Systems (FRA:2DR) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Inspire Medical Systems 3-1 Month Momentum % Related Terms
FRA:2DR vs AHCO, IART, CNMD: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, Inspire Medical Systems's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inspire Medical Systems 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Inspire Medical Systems's 3-1 Month Momentum % falls into.
Inspire Medical Systems (FRA:2DR) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inspire Medical Systems (FRA:2DR) has a 3-1 Month Momentum % of 18.64% as of Aug. 15, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Inspire Medical Systems and its competitors. According to the industry distribution chart, Inspire Medical Systems ranks #78 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 9.2%.
Is Inspire Medical Systems' 3-1 Month Momentum % too high?
Inspire Medical Systems' current 3-1 Month Momentum % is 18.64%. Based on the distribution chart, Inspire Medical Systems ranks #78 out of 850 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Inspire Medical Systems has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Inspire Medical Systems' 3-1 Month Momentum % compare to AHCO and IART?
According to the Medical Devices & Instruments industry distribution chart, Inspire Medical Systems ranks #78 out of 850 companies for 3-1 Month Momentum %. This places Inspire Medical Systems in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Inspire Medical Systems and its competitors. Inspire Medical Systems's current 3-1 Month Momentum % is 18.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire Medical Systems stock overvalued right now?
Inspire Medical Systems (FRA:2DR) has a current 3-1 Month Momentum % of 18.64%. The stock's GF Value™ is €162.88, compared to a current price of €48.60 — trading 70.2% below its estimated fair value. The current 3-1 Month Momentum % is 18.64%. Inspire Medical Systems' overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Inspire Medical Systems (FRA:2DR), the current 3-1 Month Momentum % is 18.64% as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inspire Medical Systems (FRA:2DR) Overvalued in 2026?
Based on GuruFocus' analysis, Inspire Medical Systems stock appears to be undervalued.
The current stock price of €48.60 is trading 70.2% below its estimated GF Value™ of €162.88.
Key valuation signals for FRA:2DR:
3-1 Month Momentum %: 18.64%
GF Value™: €162.88 vs. price of €48.60 (70.2% below fair value)
No single metric tells the full story. See the FRA:2DR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
57GF Score
Get the complete analysis for FRA:2DR
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2DR has been successfully added to your 
